Skip to main content
Premium Trial:

Request an Annual Quote

Eppendorf Licenses Thermal Cycler Gradient Tech to Agilent

Premium

Eppendorf said today that it has licensed patents covering gradient technology for thermal cyclers to Agilent Technologies.

The license includes US Patent No. 6,767,512, entitled "Temperature-regulating block with temperature-regulating devices;" and No. 7.074,367, entitled "Thermostated block with heat-regulating devices."

Last April, Agilent launched the SureCycler 8800 endpoint PCR instrument, which counts among its features thermal gradient technology (PCR Insider, 4/7/2011). Eppendorf utilizes the technology in its Eppendorf Mastercycler Pro Gradient, Mastercycler Nexus Gradient, and Mastercycler EP Realplex models.

In the last year, Hamburg, Germany-based Eppendorf has licensed the '512 and '367 patents to a number of life science companies, including Roche, Takara Bio, Analytik Jena, Bulldog Bio, Labnet, and Bibby Scientific.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.